SCHEMBL30535596

SCHEMBL30535596

CS(=O)(=O)Nc1cc(Cl)cc(NC(=O)c2cccc(-n3cccn3)c2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT6A Q92794 2/20 0.51
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
DHX9 Q08211 1/20 0.46
HTT P42858 4/20 0.45
ALDH1A1 P00352 3/20 0.45
MAPT P10636 3/20 0.45
LMNA P02545 2/20 0.45
TEK Q02763 1/20 0.44
HPGD P15428 2/20 0.44
KDM4E B2RXH2 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
MDM2 Q00987 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
EGFR P00533 2/20 0.43
FGFR1 P11362 2/20 0.43
KDR P35968 2/20 0.43
MAPK10 P53779 6/20 0.43
MAPK8 P45983 4/20 0.42
TNIK Q9UKE5 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25351911 1.00 KAT6A (0.51) KAT6AMEN1KMT2ADHX9HTT
SCHEMBL30535678 0.90 KAT6A (0.51) KAT6AMEN1KMT2ADHX9HTT
SCHEMBL25353685 0.90 KAT6A (0.51) KAT6AMEN1KMT2ADHX9HTT
SCHEMBL31610063 0.89 DHX9 (0.57) KAT6AMEN1KMT2ADHX9HTT
SCHEMBL25431434 0.89 DHX9 (0.57) KAT6AMEN1KMT2ADHX9HTT
SCHEMBL25350503 0.83 HTT (0.43) KAT6AMEN1KMT2ADHX9HTT
SCHEMBL30535005 0.83 HTT (0.43) KAT6AMEN1KMT2ADHX9HTT
SCHEMBL25352121 0.82 MEN1 (0.41) MEN1KMT2ADHX9HTTALDH1A1
SCHEMBL25430854 0.82 DHX9 (0.42) MEN1KMT2ADHX9HTTALDH1A1
SCHEMBL30535450 0.82 DHX9 (0.42) MEN1KMT2ADHX9HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4479138-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF Accent Therapeutics, Inc. (US) 2024-12-25 EP disclosed
WO-2023154519-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2023-08-17 WO disclosed